Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Cancer and Chemotherapy Reviews is Scopus-indexed (Q4, CiteScore 0.3). Published by Permanyer Publications.
Checked against the index lists dated .
ISSN 1885-740XVerify ISSN ↗2339-8728Verify ISSN ↗
Publisher: Permanyer Publications
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 399 / 428 | 6th | Q4 |
| Pharmacology (medical) | 260 / 278 | 6th | Q4 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2024–2025 (also 2007–2022), best quartile Q4, CiteScore 0.3.
Cancer and Chemotherapy Reviews is Q4 in Oncology (rank 399 of 428) and Q4 in Pharmacology (medical) (rank 260 of 278), by CiteScore 2025.
Cancer and Chemotherapy Reviews is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 0.3, quartile Q4, 6th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.103, quartile Q4, with an H-index of 4.
Cancer and Chemotherapy Reviews is published by Permanyer Publications. Its print ISSN is 1885-740X and its online ISSN is 2339-8728.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
Cancer and Chemotherapy Reviews has an h-index of 0 and a 2-year mean of 0 citations per paper (OpenAlex). Its Scopus CiteScore is 0.3, quartile Q4. On 2-year citations it ranks #402 of 424 Scopus journals in Oncology.
Cancer and Chemotherapy Reviews published 1 papers in 2025; its busiest recent year was 2024 with 1. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.